PCSK9 and cystic fibrosis: These data demonstrate that CF, in the nanomolar range, can cause a significant reduction of PCSK9 expression at the mRNA and protein levels in a variety of cultured hepatocyte cell models and that the inhibition likely occurs at the transcriptional level.